GlassScriptPhysician profile
David Michael Ciminello
NPI 1164442398
$1,441.44
in general payments reported to CMS, 2019-2025
19 companies · $152 in 2025
The $152 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $17.05 · 2021: $136 · 2022: $200 · 2023: $268 · 2024: $235 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $199.17 | 2019-2023 | Auvi-Q |
| Merck Sharp & Dohme LLC | $198.56 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Neos Therapeutics, LP | $167.20 | 2019-2025 | Cotempla Xr-Odt, Adzenys Xr-Odt |
| Pfizer INC. | $149.81 | 2019-2023 | |
| Cranial Technologies, INC | $132.04 | 2019-2025 | Doc Band |
| Ironshore Pharmaceuticals INC. | $125.64 | 2019-2024 | Jornay Pm |
| Corium, LLC | $100.43 | 2021-2024 | Azstarys |
| Sobi, INC | $72.50 | 2019 | |
| Tris Pharma INC | $65.12 | 2019-2022 | |
| Sanofi Pasteur INC. | $50.29 | 2021-2025 | |
| Shire North American Group INC | $28.25 | 2019 | |
| Verrica Pharmaceuticals INC. | $25.78 | 2024 | Ycanth |
| Astrazeneca Pharmaceuticals LP | $23.88 | 2024 | Flumist Quadrivalent |
| Supernus Pharmaceuticals, INC. | $20.78 | 2021 | |
| Seqirus USA INC | $19.09 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $18.76 | 2025 | Relexxii |
| Pierre Fabre Pharmaceuticals, INC. | $14.84 | 2022 | |
| Phadia US INC. | $14.78 | 2025 | Immunocap |
| Collegium Pharmaceutical, INC. | $14.52 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ciminello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.